Evidence map›Paper›PMID 27126822›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2016

G1 Domain of Versican Regulates Hyaluronan Organization and the Phenotype of Cultured Human Dermal Fibroblasts.

Mervyn J Merrilees, Ning Zuo, Stephen P Evanko, Anthony J Day, Thomas N Wight

Open access · hybridAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. V3: an enigmatic isoform of the proteoglycan versican.American journal of physiology. Cell physiology · 2023
    Review
  3. Methods for isolating and analyzing physiological hyaluronan: a review.American journal of physiology. Cell physiology · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. A Role for HAPLN1 During Phenotypic Modulation of Human Lung Fibroblasts In Vitro.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Article
  8. Versican: A Dynamic Regulator of the Extracellular Matrix.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2020
    Review
  9. Article
  10. The synthesis and secretion of versican isoform V3 by mammalian cells: A role for N-linked glycosylation.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Article
  11. Review
  12. A role for proteoglycans in vascular disease.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  13. Article
  14. Article
  15. Provisional matrix: A role for versican and hyaluronan.Matrix biology : journal of the International Society for Matrix Biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mervyn J MerrileesDepartment of Anatomy and Medical Imaging, School of Medical Sciences, University of Auckland, Auckland, New Zealand (MJM,NZ)
Ning ZuoDepartment of Anatomy and Medical Imaging, School of Medical Sciences, University of Auckland, Auckland, New Zealand (MJM,NZ)
Stephen P EvankoMatrix Biology Program, Benaroya Research Institute, Seattle, Washington (SPE,TNW)
Anthony J DayWellcome Trust Centre for Cell-Matrix Research, The Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom (AJD)
Thomas N WightMatrix Biology Program, Benaroya Research Institute, Seattle, Washington (SPE,TNW)
Benaroya Research InstituteWellcome Centre for Cell-Matrix Research · GBUniversity of Manchester · GB

Funding

Thymic Stromal Lymphopoietin (TSLP) and Lung Inflammation and ImmP01HL098067 · NHLBI · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI FREVERT, CHARLES WAYNE · 2010 to 2014
$13.5M
Engineering vascular replacements for strength and elasticityR01EB012558 · NIBIB · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI VERNON, ROBERT B, WIGHT, THOMAS N · 2011 to 2014
$2.3M
Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) FailureR41HL106967 · NHLBI · MATREXA, LLC · PI WIGHT, THOMAS N · 2011 to 2012
$677k
NHLBI NIH HHS P01 HL098067NHLBI NIH HHS R41 HL106967NIBIB NIH HHS R01 EB012558
6 · The paper itself

Abstract

Variants of versican have wide-ranging effects on cell and tissue phenotype, impacting proliferation, adhesion, pericellular matrix composition, and elastogenesis. The G1 domain of versican, which contains two Link modules that bind to hyaluronan (HA), may be central to these effects. Recombinant human G1 (rhG1) with an N-terminal 8 amino acid histidine (His) tag, produced in Nicotiana benthamiana, was applied to cultures of dermal fibroblasts, and effects on proliferation and pericellular HA organization determined. rhG1 located to individual strands of cell surface HA which aggregated into structures resembling HA cables. On both individual and aggregated strands, the spacing of attached rhG1 was similar (~120 nm), suggesting interaction between rhG1 molecules. Endogenous V0/V1, present on HA between attached rhG1, did not prevent cable formation, while treatment with V0/V1 alone, which also bound to HA, did not induce cables. A single treatment with rhG1 suppressed cell proliferation for an extended period. Treating cells for 4 weeks with rhG1 resulted in condensed layers of elongated, differentiated α actin-positive fibroblasts, with rhG1 localized to cell surfaces, and a compact extracellular matrix including both collagen and elastin. These results demonstrate that the G1 domain of versican can regulate the organization of pericellular HA and affect phenotype.

Indexed as

Cell ProliferationCells, CulturedFibroblastsHistidineHumansHyaluronic AcidProtein DomainsRecombinant ProteinsSkinVersicansHistidineHyaluronic AcidRecombinant ProteinsVCAN protein, humanVersicanscablesdifferentiationG1 domainhyaluronanversican

Identifiers

PMID27126822
PMCPMC4888412
OpenAlexW2342523191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.